Lloyd Segal

Lloyd M.
Segal was the founder of Repare Therapeutics, Inc., founded in 2016, where the titles held included President, CEO, Secretary & Director from 2016 to 2025.
Mr. Segal is also the founder of Caprion Pharmaceuticals, Inc...
Mr. Segal currently serves as Independent Director at Aktis Oncology, Inc. since 2021, Director at Therapure Biopharma, Inc. since 2016, and Director at American Funds Growth Fund of America.
Former positions include Chief Executive Officer at Advanced Bioconcept Ltd., Chief Executive Officer at Thallion Pharmaceuticals, Inc. from 2007 to 2010, Chairman at LMC Diabetes & Endocrinology Ltd., Chairman at MedReleaf Corp., Director at Pembroke American Growth Fund Inc, Director at Biovail Corp., Independent Director at Diagnos, Inc. from 2014 to 2015, Independent Director at Bausch Health Cos., Inc. from 2012 to 2014, Managing Partner at Persistence Capital Partners LP from 2010 to 2016, Managing Partner at PCP Management, Inc., Management Consultant at McKinsey & Co., Inc. (Canada), and Entrepreneur in Residence at Versant Ventures Canada Ltd. from 2017 to 2020.
Education includes undergraduate studies at Brandeis University and an MBA from Harvard Business School.